港股异动 | CRO概念股早盘普跌药明康德预计今年营收增速创十年新低花旗称指引令人失望

智通财经03-22

智通财经APP获悉，CRO概念股早盘普跌，截至发稿，药明康德(02359)跌4.86%，报38.2港元；泰格医药(03347)跌4.48%，报29.85港元；昭衍新药(06127)跌4.47%，报9.18港元；康龙化成(03759)跌4.21%，报9.79港元。消息面上，药明康德此前公告，预计2024年收入383亿元至405亿元，相比2023年全年增长-5.06%至0.39%。即使按照乐观预计的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2421429887?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-22 10:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2421429887","market":"hk","top_or_hot":-1,"title":"港股异动 | CRO概念股早盘普跌 药明康德预计今年营收增速创十年新低 花旗称指引令人失望","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，CRO概念股早盘普跌，截至发稿，药明康德(02359)跌4.86%，报38.2港元；泰格医药(03347)跌4.48%，报29.85港元；昭衍新药(06127)跌4.47%，报9.18港元；康龙化成(03759)跌4.21%，报9.79港元。消息面上，药明康德此前公告，预计2024年收入383亿元至405亿元，相比2023年全年增长-5.06%至0.39%。即使按照乐观预计的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1090302.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | CRO概念股早盘普跌 药明康德预计今年营收增速创十年新低 花旗称指引令人失望</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | CRO概念股早盘普跌 药明康德预计今年营收增速创十年新低 花旗称指引令人失望\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-22 10:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1090302.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，CRO概念股早盘普跌，截至发稿，药明康德(02359)跌4.86%，报38.2港元；泰格医药(03347)跌4.48%，报29.85港元；昭衍新药(06127)跌4.47%，报9.18港元；康龙化成(03759)跌4.21%，报9.79港元。消息面上，药明康德此前公告，预计2024年收入383亿元至405亿元，相比2023年全年增长-5.06%至0.39%。即使按照乐观预计的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1090302.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"C","symbol_name":"花旗","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1090302.html","article_id":"2421429887","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2421429887","pubTimestamp":1711074732,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"消息面上，药明康德此前公告，预计2024年收入383亿元至405亿元，相比2023年全年增长-5.06%至0.39%。即使按照乐观预计的405亿元计算，公司营收增速也将创下近十年以来的新低。中泰国际表示，预计药明康德2024-25年收入将逊于早先预期。花旗发布研报称，药明康德今年的指引令人失望，进一步削弱市场信心，反映增长前景不明确。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"C":"花旗","YANG":"三倍做空富时中国ETF-Direxion","07226":"XL二南方恒科","YINN":"三倍做多富时中国ETF-Direxion","03759":"康龙化成","02359":"药明康德","06127":"昭衍新药","03347":"泰格医药"},"translate_title":"Hong Kong stocks changed CRO concept stocks fell in early trading. Minkant expects revenue growth to hit a ten-year low this year. Citi said the guidance was disappointing","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1,"07226":1,"C":1,"YANG":1,"YINN":1,"03347":0.9,"03759":0.9,"06127":0.9},"content_text":"智通财经APP获悉，CRO概念股早盘普跌，截至发稿，药明康德(02359)跌4.86%，报38.2港元；泰格医药(03347)跌4.48%，报29.85港元；昭衍新药(06127)跌4.47%，报9.18港元；康龙化成(03759)跌4.21%，报9.79港元。消息面上，药明康德此前公告，预计2024年收入383亿元至405亿元，相比2023年全年增长-5.06%至0.39%。即使按照乐观预计的405亿元计算，公司营收增速也将创下近十年以来的新低。中泰国际表示，预计药明康德2024-25年收入将逊于早先预期。花旗发布研报称，药明康德今年的指引令人失望，进一步削弱市场信心，反映增长前景不明确。因应其今年指引，以及美国制裁的不明朗性，将其2024及2025财年收入预测分别下调22%及35%，每股盈利预测分别下调19%及34%，并预期长远收入增较为温和，因此将其目标价由175港元大幅下调至90港元。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2421429887"}

港股异动 | CRO概念股早盘普跌 药明康德预计今年营收增速创十年新低 花旗称指引令人失望

精彩评论

港股异动 | CRO概念股早盘普跌药明康德预计今年营收增速创十年新低花旗称指引令人失望